FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067596 [Registered on: 17/05/2024] Trial Registered Prospectively
Last Modified On: 14/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study on Efficacy and Safety of Intraoperative Intracameral Injection Phenocaine in comparison with Preoperative Topical mydriatics in cataract surgery - Randomized control trial 
Scientific Title of Study   Efficacy and Safety of Intraoperative Intracameral Injection Phenocaine in comparison with Preoperative Topical mydriatics in cataract surgery- Randomized control trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tharani M 
Designation  Post Graduate Trainee Ophthalmology 
Affiliation  Regional Institute of Medical Sciences Imphal 
Address  Duty Doctor Room 103 Male Eye ward 101 Department of Ophthalmology Regional Institute of Medical Sciences Imphal

Imphal West
MANIPUR
795004
India 
Phone  8608944873  
Fax    
Email  tharanim2410@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Professor Y Chingsuingamba Meitei 
Designation  Professor And Head of Department of Ophthalmology 
Affiliation  Regional Institute of Medical Sciences Imphal 
Address  Head of department Room 102 Male Eye Ward 101 Department of Ophthalmology

Imphal West
MANIPUR
795004
India 
Phone  9436026405  
Fax    
Email  drcyumnam2003@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tharani M 
Designation  Post Graduate Trainee Ophthalmology 
Affiliation  Regional Institute of Medical Sciences Imphal 
Address  Duty Doctor Room 103 Male Eye Ward 101 Department of Ophthalmology Regional Institute of Medical Sciences Imphal

Imphal West
MANIPUR
795004
India 
Phone  8608944873  
Fax    
Email  tharanim2410@gmail.com  
 
Source of Monetary or Material Support  
Regional Institute of Medical Sciences Imphal 
 
Primary Sponsor  
Name  Dr Tharani M 
Address  Duty Doctor Room 103 Male Eye Ward 101 Department of Ophthalmology Regional Institute of Medical Sciences Imphal 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NOT APPLICABLE   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tharani M  RIMS Hospital , Imphal  Eye operation theatre 5 and Male Eye Ward 101 Department of Ophthalmology RIMS,IMPHAL
Imphal West
MANIPUR 
8608944873

tharanim2410@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research Ethics Board RIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H259||Unspecified age-related cataract,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intracameral Mydriatics  To Test the Efficacy And Safety of Intraoperative Intracameral Mydriatic Injection containing Lignocaine 1% Phenylephrine 0.1% Tropicamide 0.02% given once during the surgery intraoperatively and later can be given whenever needed the Intervention will be done for 18 months 
Comparator Agent  Topical Mydriatics  To Test the Efficacy And Safety Of Preoperative Topical Mydriatic Eye drop Tropicamide 0.8% and Phenylephrine 5% given in the eye to be operated every 15 minutes from before 1 hour of Surgery Intervention is to be done for a period of 18 months 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Uncomplicated Cataract Patients
Pupil Diameter Atleast 6mm Preoperatively 
 
ExclusionCriteria 
Details 
Uveitis
Intake of alpha blockers
Use of topical or systemic NSAIDS/prostaglandins/miotics
Presence of corneal opacities,pupillary deformities
History of surgery in the same eye
Congenital cataract and history of ocular trauma
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Pupil size
2.Postoperative visual acuity
3.Corneal edema
4.ANTERIOR CHAMBER reaction

 
Post Operative Day 1

 
 
Secondary Outcome  
Outcome  TimePoints 
not applicable  not applicable 
 
Target Sample Size   Total Sample Size="84"
Sample Size from India="84" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   30/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="20" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Novelty of the study: Cataract surgery  is a very common surgery undertaken in Ophthalmology. Adequate pupillary mydriasis and good anesthesia is crucial for successful cataract surgery. Thus, this study is undertaken to determine the efficacy and safety of intraoperative intracameral mydriatics in comparison with preoperative topical mydriatics.

Study designHospital-based Randomized control study

Objectives of the study: To determine the efficacy and safety of intracameral mydriatic (tropicamide 0.02%+phenylephrine0.31%+lidocaine1%) in comparison with the standard preoperative mydriatics(tropicamide0.8%+phenylephrine5%).

 

Participants: 42   patients in each group between the age of 40 – 90 years of age undergoing cataract surgery  attending Ophthalmology OPD.

 

Sampling/Recruitment /Collection: All uncomplicated cataract patients undergoing cataract surgery attending Ophthalmology OPD Regional Institute of Medical Sciences Hospital   will be enrolled in the study.

 

How randomization (if any) is planned: Block randomization(block size=4)

 

Independent Variables (include intervention if trial): Age and sex

 

Outcome Variables and measurements: pupil size, postoperative day one visual acuity,corneal edema and Anterior chamber(AC) inflammation scores.

 

Plan of Statistical Analysis: Data collected in the proforma will be checked for consistency and completeness. Then they will be entered in the IBM SPSS version 21.0 software (IBM Corp. Armonk. NY, USA) for analysis. Descriptive statistics like mean, percentage and standard deviation will be used to represent age, sex. Pupil size will be analysed by Chi Square test .Postoperative day one visual acuity, corneal edema scores and AC inflammation scores will be compared and statistically analysed using the paired t-test and independent t-test. A p-value of <0.05 will be considered statistically significant.

 

 


 
Close